Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at SJM's multiple
$1.4064.9% below market
0.94 ZNTL revenue / share×1.49x SJM P/S=$1.40
Market $3.99Implied $1.40
SJM · current priceP/S 1.49x
$126.08Latest market snapshot
Implied fair value · at ZNTL's multiple
$359.36185.0% above market
84.73 SJM revenue / share×4.24x ZNTL P/S=$359.36
Market $126.08Implied $359.36